Literature DB >> 30582296

Low-dose combination therapy to control sustained ambulatory hypertension-Basic principles and future directions.

Panagiotis I Georgianos1, Vassilios Liakopoulos1, Pantelis E Zebekakis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30582296      PMCID： PMC8030336          DOI： 10.1111/jch.13468

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  16 in total

1.  Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice.

Authors:  Giovanni Corrao; Andrea Parodi; Antonella Zambon; Franca Heiman; Alessandro Filippi; Claudio Cricelli; Luca Merlino; Giuseppe Mancia
Journal:  J Hypertens       Date:  2010-07       Impact factor: 4.844

2.  Prognostic Value of Masked Uncontrolled Hypertension.

Authors:  Sante D Pierdomenico; Anna M Pierdomenico; Francesca Coccina; Denis L Clement; Marc L De Buyzere; Dirk A De Bacquer; Iddo Z Ben-Dov; Wanpen Vongpatanasin; José R Banegas; Luis M Ruilope; Lutgarde Thijs; Jan A Staessen
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

3.  2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension.

Authors:  Bryan Williams; Giuseppe Mancia; Wilko Spiering; Enrico Agabiti Rosei; Michel Azizi; Michel Burnier; Denis L Clement; Antonio Coca; Giovanni de Simone; Anna Dominiczak; Thomas Kahan; Felix Mahfoud; Josep Redon; Luis Ruilope; Alberto Zanchetti; Mary Kerins; Sverre E Kjeldsen; Reinhold Kreutz; Stephane Laurent; Gregory Y H Lip; Richard McManus; Krzysztof Narkiewicz; Frank Ruschitzka; Roland E Schmieder; Evgeny Shlyakhto; Costas Tsioufis; Victor Aboyans; Ileana Desormais
Journal:  J Hypertens       Date:  2018-10       Impact factor: 4.844

4.  Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients: a matched cohort study.

Authors:  Alan H Gradman; Hélène Parisé; Patrick Lefebvre; Heather Falvey; Marie-Hélène Lafeuille; Mei Sheng Duh
Journal:  Hypertension       Date:  2012-11-26       Impact factor: 10.190

5.  Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials.

Authors:  David S Wald; Malcolm Law; Joan K Morris; Jonathan P Bestwick; Nicholas J Wald
Journal:  Am J Med       Date:  2009-03       Impact factor: 4.965

Review 6.  Therapeutic Inertia and Treatment Intensification.

Authors:  Robina Josiah Willock; Joseph B Miller; Michelle Mohyi; Ahmed Abuzaanona; Meri Muminovic; Phillip D Levy
Journal:  Curr Hypertens Rep       Date:  2018-01-29       Impact factor: 5.369

7.  Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials.

Authors:  M R Law; N J Wald; J K Morris; R E Jordan
Journal:  BMJ       Date:  2003-06-28

8.  Effect of long-term antihypertensive treatment on white-coat hypertension.

Authors:  Giuseppe Mancia; Rita Facchetti; Gianfranco Parati; Alberto Zanchetti
Journal:  Hypertension       Date:  2014-09-22       Impact factor: 10.190

9.  Initial monotherapy and combination therapy and hypertension control the first year.

Authors:  Brent M Egan; Dipankar Bandyopadhyay; Stephanie R Shaftman; C Shaun Wagner; Yumin Zhao; Kristina S Yu-Isenberg
Journal:  Hypertension       Date:  2012-05-07       Impact factor: 10.190

10.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

Authors:  Jackson T Wright; Jeff D Williamson; Paul K Whelton; Joni K Snyder; Kaycee M Sink; Michael V Rocco; David M Reboussin; Mahboob Rahman; Suzanne Oparil; Cora E Lewis; Paul L Kimmel; Karen C Johnson; David C Goff; Lawrence J Fine; Jeffrey A Cutler; William C Cushman; Alfred K Cheung; Walter T Ambrosius
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.